Notice of first launch, interruption or termination of supply of a human drug
 Date ▲HolderCodeDrugDate fromSubject
 23.4.2024B.Braun Melsungen AG (BME)26923Kaliumchlorid B. Braun 7,45 % (con inf 20x20 ml (amp.PE))3.6.2024R
 23.4.2024B.Braun Melsungen AG (BME)33976Ringer´s Braun Injection (sol inf 10x500 ml (PE obal))23.4.2024O
 22.4.2024STADA Arzneimittel AG (STD)3666DUrapidil Stada 60 mg tvrdé kapsuly s predĺženým uvoľňovaním (cps pld 50x60 mg (fľ.HDPE))28.4.2024R
 22.4.2024STADA Arzneimittel AG (STD)5962CPregabalin STADA Arzneimittel 150 mg (cps dur 56x150 mg (blis.Al/PVC))22.4.2024O
 22.4.2024Eli Lilly Nederland B.V. (LIL-NL-2)3883DLyumjev 100 jednotiek/ml injekčný roztok v injekčnej liekovke (sol inj 1x10 ml/1000 U (liek.skl.inj.))23.4.2024O
 22.4.2024BB Pharma a.s. (BBP-CZ-1)2194BPENDEPON COMPOSITUM (plv inu 1x1,5 MU (liek.inj.))6.5.2024O
 22.4.2024Teva B.V. (TEV-NL-4)00802OPHTHALMO-SEPTONEX (int opo 1x10 ml (fľ.plast.biela+kvapkadlo))18.4.2024O
 22.4.2024Teva B.V. (TEV-NL-4)2870BRazagilin ratiopharm 1 mg tablety (tbl 100x1 mg (blis.Al/Al))17.4.2024O
 22.4.2024Teva B.V. (TEV-NL-4)90126AZILECT 1 mg tablety (tbl 28x1 mg (blis.Al/Al))17.4.2024O
 22.4.2024Teva B.V. (TEV-NL-4)2868BRazagilin ratiopharm 1 mg tablety (tbl 28x1 mg (blis.Al/Al))17.4.2024O
 22.4.2024Teva B.V. (TEV-NL-4)90128AZILECT 1 mg tablety (tbl 100x1 mg (blis.Al/Al))17.4.2024O
 22.4.2024STALLERGENES (SLG-1)85040Oralair 300 IR (tbl slg 3x30x300 IR (blis. PA/Al/PVC/Al))23.4.2024O
 22.4.2024STALLERGENES (SLG-1)85039Oralair 300 IR (tbl slg 1x30x300 IR (blis. PA/Al/PVC/Al))23.4.2024O
 22.4.2024Hikma Farmaceutica (Portugal) S.A. (HKP-P)71854CIPROLON 500 (tbl flm 10x500 mg (blis. PVC/Al))22.4.2024O
 22.4.2024B.Braun Melsungen AG (BME)4143CIbuprofen B. Braun 400 mg (sol inf 10x400 mg/100 ml (fľ.LDPE))22.4.2024O

Subject means:
U-Placement of medicine to Slovakian market, R-Discontinuation of medicine supply to Slovakian market,
O-Resumption of medicine supply to Slovakian market, Z-Cancelation of medicine supply to Slovakian market


Date from
From
To